Emails obtained by MobiHealthNews show Apple has been meeting with the FDA since July about two cardiac monitoring products. In the messages, Apple lawyer Robin Goldstein discussed “an introductory meeting where we will want to talk about two possible (and related) products in the cardiac space, as well as the associated regulatory and quality systems and requirements.” The emails don’t contain any information about the products,…
